BMS 140 857 (Sprycel 140 mg)

Generic Name: dasatinib

Pill imprint BMS 140 857 has been identified as Sprycel 140 mg.

Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substance Act (CSA).

Sprycel

Generic Name:

dasatinib

Imprint:

BMS 140 857

Strength:

140 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

BCR-ABL tyrosine kinase inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Bristol-Myers Squibb

National Drug Code (NDC):

00003-0857

Inactive Ingredients:

croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
polyethylene glycol
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.